Loading
Loading

Carrier Screening Market Scope, Size and Forecast Analysis Report 2030

Carrier Screening Market report by MarkNtel Advisors, a leading market research company, provides an in-depth analysis of the market’s size, share, and growth prospects."

Carrier Screening Market Poised for Robust Growth, forecasted to Expand at 20.7% CAGR from 2024-30

MarkNtel Advisors has released its latest report highlighting strong growth in The Global Carrier Screening Market size was valued at around USD 2.09 billion in 2023 & is estimated to grow at a CAGR of around 20.7% during the forecast period, i.e., 2024–30.

Report Coverage

This report offers a comprehensive analysis of the Carrier Screening Market, providing valuable insights across historical trends, current dynamics, and future forecasts.

  • Base Year: 2023
  • Forecast Years: 2024-30
  • Historical Years: 2019-22

Carrier Screening Market Overview

The growth of this market primarily stems from the advancement and accessibility of expanded carrier screening panels, which encompass a broad spectrum of genetic conditions, driving market expansion. Comprehensive panels deliver more comprehensive evaluations, prompting healthcare providers to embrace them for furnishing patients with extensive genetic insights.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Empower Your Business Decisions – Download a Free Sample Now  -  https://www.marknteladvisors.com/query/request-sample/carrier-screening-market.html

Carrier Screening Market Segmentation Outlook

The Carrier Screening is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:

By Product & Service

  • Services
  • Products

By Type

  • Expanded Carrier Screening
    • Predesigned Panel Testing
    • Customized Panel Testing
  • Targeted Disease Carrier Screening

By Medical Condition

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Others

By Technology

  • DNA Sequencing
  • PCR
  • DNA Microarrays
  • Others

By End-User

  • Hospitals & Medical Centers
  • Clinical Laboratories
  • Fertility Clinics
  • Others

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Carrier Screening Market Driver

Rising Prevalence of Genetic Disorders – The increasing occurrence and understanding of genetic disorders are major factors driving the growth & expansion of carrier screening services. Carrier screening is a crucial methodology for pinpointing individuals who possess one copy of a gene mutation linked to a particular genetic ailment. Approximately 10,000 distinct types of single-gene diseases, also known as monogenic diseases, exist, wherein mutations in a single gene cause the ailment. According to the World Health Organization Report, it has been estimated that 9 out of every 999 individuals are adversely impacted by these conditions. This suggests that about 85 million people are grappling with one of these diseases worldwide.

Click here to access the full Carrier Screening Market report and take advantage of our special pricing offer-   https://www.marknteladvisors.com/research-library/carrier-screening-market.html

Top Carrier Screening Market Brands & Their Strategic Market Positioning

MarkNtel Advisors Research identifies Natera, Inc., Quest Diagnostics Incorporated, Fulgent Genetics, Invitae Corporation, Eurofins Scientific, Opko Health, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Illumina, Inc., Centogene N.V., Diasorin S.P.A., Otogenetics, Genetech, Laboratory Corporation of America Holdings, and Others as key players shaping the market landscape.

Carrier Screening Market News

  • 2022: OPKO Health Inc. completed the acquisition of ModeX Therapeutics, intending to utilize proprietary immunotherapy technology for the treatment of cancerous and infectious diseases under the Oncology department.

Key Questions Answered in the Report

  • What is the market size (value & volume) along with the current & future trends, growth factors & challenges, etc.?
  • How the industry has been evolving, and which segments would dominate the market during the forecast period?
  • What are the key opportunity areas that companies foresee in the coming years 2030?
  • Who are the key players in the market, and what are their competitive strengths?
  • What are the key growth drivers & challenges associated with the market, and how would they impact the market through the forecast period?

Need tailored data? We offer customized forecasts by region, product segmentation, and competitive intelligence upon request — now with an exclusive special pricing offer – Customized Link

Our Trusted Experts Are Here to Help:

At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.

Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.


james williams

14 Blog indlæg

Kommentarer